Digital Health Startups

FIZE Medical develops an automated digital platform for fluid management in clinical settings, using real-time data to support clinical decision-making. Its FIZE kUO system aims to provide precise measurement of patient fluid outputs to enable earlier intervention.

1 investor

Flagship Biosciences is a CLIA-certified, CAP-accredited spatial biology and biomarker services company that combines AI-powered tissue analysis with scientific consultation. It serves pharmaceutical and biotech companies in drug development and diagnostics.

1 investor

Flashaid provides a support layer for employer group health plans, offering guided cashless hospitalization assistance, dedicated claims managers, teleconsultations, and an admin dashboard for HR and finance teams. It operates through IRDAI-registered insurer partners in India, focusing on helping employees actually use their health benefits after a plan is launched.

1 investor

Flax provides AI-driven automation for skilled nursing and post-acute care teams, handling referral screening, insurance eligibility verification, intake, care planning, and claims/reimbursement management. It aims to improve clinical outcomes, documentation accuracy, and compliance while boosting reimbursement.

1 investor

Flexspeak develops augmentative and alternative communication (AAC) software that supports multilingual users, designed for non-speaking individuals and families in diverse language households.

1 investor

FlexTogether offers respiratory care and recovery programs through guided physical therapy and wellness classes. The company serves patients recovering from lung disease and those seeking respiratory rehabilitation.

1 investor

Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics. The company also provides end-to-end genomics solutions including data generation, analysis, and bioinformatics support for research and clinical projects.

1 investor

Floracene provides independent surgery centers with software to identify lower-cost clinically equivalent orthopedic and spine implants based on their existing manufacturer contracts. The platform helps physician-owners reduce implant costs by presenting alternative options that meet clinical requirements for specific procedures.

1 investor

Flore offers a microbiome "test-to-treat" program in which accredited labs run at-home gut microbiome and neurotransmitter urine tests, and Flore then builds and manufactures a personalized supplement formula based on the individual's results. The formulas target the gut–brain axis and other body systems such as digestion, metabolism, immunity, and mood, and are updated when a customer retests.

1 investor

Flouria is a digital women's health clinic that connects patients with specialised doctors for testing, insights, and personalised treatment plans across areas like perimenopause, postmenopause, postpartum, PMOS/PCOS, and fertility. Care is delivered through its app, where users chat and video call with experts, access courses, and track symptoms, with a stated focus on Europe and the Netherlands.

1 investor

Flourish Research operates a network of clinical trial research sites specializing in patient recruitment and retention across therapeutic areas including cardiometabolic disease, neuroscience, oncology, and infectious diseases. The company serves pharmaceutical sponsors and contract research organizations (CROs) by providing integrated site infrastructure, patient access, and standardized operations for studies across all research phases.

1 investor

Flow provides a consumer-facing neurostimulation device using transcranial direct current stimulation (tDCS) for depression treatment. The technology is clinically validated and available for at-home use to balance activity in mood-regulating brain regions.

1 investor

FlowReserve uses CFD numerical simulation of 3D vascular geometry to reproduce blood circulation and calculate FFRct, producing automated diagnostic reports for cardiologists. The company applies computational fluid dynamics to non-invasive assessment of coronary artery disease.

1 investor

FlowRx builds deterministic AI automation for pharmacy workflows such as data entry, eRx processing, refills, billing, prior authorization, and inventory optimization. It targets independent pharmacies, overlaying existing systems with compliance dashboards and human review of exceptions.

1 investor

flowww is management software for clinics and centers in the beauty, aesthetic medicine, health, and wellness sectors, offering digital medical records with e-signatures, appointment booking, stock traceability, automated marketing, and real-time analytics. It includes an AI medical assistant that auto-completes forms and automates repetitive operational tasks. Marketed primarily in Spain.

1 investor

flowww provides cloud-based management software for beauty, aesthetic medicine, health, and wellness clinics, with tools for clinical records, appointment booking, digital consent signatures, marketing automation, and reporting. It also offers a medical AI assistant that fills out forms automatically and automates repetitive clinical and operational tasks.

1 investor

Floy develops artificial intelligence software that analyzes radiological images to detect conditions beyond the primary diagnostic question, such as osteoporosis and cardiovascular risk factors. The tools support radiologists in routine reporting with objective, measurable assessments and comparisons over time.

1 investor

Fluorobiotech develops molecular enzymes—using its patented SelfPrep technology—for in vitro transcription, mRNA synthesis, and transcriptomics, serving researchers, developers, and manufacturers with molecular biology reagents. The company produces ISO 13485-certified enzymes at scales from micrograms to grams for both preclinical studies and commercial volumes.

1 investor

Flymedi operates an online directory and matching service that connects patients with verified clinics and doctors abroad for medical treatments such as bariatric and general surgery. It provides price quotes, doctor-reviewed medical guides, and patient reviews, ranking providers via its FlymediScore and earning success fees from clinics rather than from patients.

1 investor

Pelvital is a medical device company that develops FDA-cleared in-home treatments for stress urinary incontinence and pelvic floor muscle weakness in women, using a proprietary mechanotherapy technology. The company serves women suffering from incontinence and healthcare providers seeking non-surgical treatment alternatives.

1 investor

Focal Healthcare is a medical device company that builds image-guided systems for physicians to perform targeted prostate procedures such as fusion biopsy and focal therapy. Its products aim to improve the accuracy and accessibility of prostate cancer diagnosis and treatment.

1 investor

WELL Mental Health & Wellness offers virtual and in-person therapy along with structured issue-based programs, matching clients to registered therapists. Part of the WELL Health Medical Centre network, it operates through select clinics in British Columbia, Alberta, Ontario, and Manitoba, Canada.

1 investor

Fofuuu offers gamified apps for early childhood learning and development, covering skills such as fine motor coordination, literacy, phonological awareness, and cognition for children from age two and a half, including support for kids with autism, Down syndrome, or learning disorders. It also provides tools for speech therapists to turn speech therapy exercises into games and assign personalized home lessons.

1 investor

Fondation Botnar is a philanthropic foundation that funds research, innovative programmes, and purpose-driven early-stage companies in low- and middle-income countries. It focuses on projects that improve young people's wellbeing through evidence-based interventions and technology solutions that are affordable, accessible, and equitable.

1 investor